Fali tu jedan deo jednacine, mislim da je mislila dobro

9 minutes ago, Indy said:

Fali tu jedan deo jednacine, mislim da je mislila dobro

 

или се куцач текста мало занео

 

Jedini problem Astro Zeke je cena, tj jeftinoća i baš ništa drugo.

 

A suviše je lakomih govana koja pokušavaju da zarade na svaki način, pa i na račun hiljada i hiljada mrtvih.

Quote

A modified version of AstraZeneca's (AZN.L) COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the end of 2021, an AstraZeneca official in Austria said in an interview published on Sunday.

Sarah Walters, AstraZeneca's Austria country manager, told the Kurier newspaper that studies, so far, indicating the existing AstraZeneca vaccine was less effective against the more infectious variant first documented in South Africa were "too small to draw final conclusions".

"In the meantime, AstraZeneca and Oxford University have started on modifications to the vaccine for the South African variant and we expect it will be ready by the end of the year, should it be needed," Walters told the Kurier.

https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-could-have-covid-19-vaccine-against-variant-by-end-2021-austrian-2021-04-18/

Edited April 18, 20213 yr by vememah

On 17.4.2021. at 19:00, dùda said:

 

 

 

(ceo niz)

Ovo zaratilo ?

 

Edit: evo i Topol je još 15.4. rekao da se podaci za iRNK vakcine ne slažu.

 

 

 

Edited April 21, 20213 yr by vememah

 

Da ponovimo još jednom, jedini problem koji AZ ima je cena. Da je deset puta skuplja, nikakvih zamerki ne bi bilo.

 

 

Edited April 22, 20213 yr by vememah

Quote

Christian Drosten, the head virologist at Berlin's Charite hospital, also did not see immediate reason for alarm with the new [Indian] variant. The next generation of vaccines will only need "a slight update" to reach "most of the immune escape mutants" with comparably "little effort," Drosten had said in his regular podcast back in March.

https://www.dw.com/en/vaccines-appear-effective-against-india-covid-variant/a-57344037

 

 

 

 

Dosta zanimljiv članak o proizvodnji iRNK i vektorskih vakcina.

https://www.chemistryworld.com/news/why-manufacturing-covid-vaccines-at-scale-is-hard/4013429.article

Treća iRNK vakcina, koja bi uskoro mogla biti odobrena, mnogo je termički stabilnija, treća faza njenog ispitivanja se privodi kraju i EMA je započela onaj sukcesivni pregled dokumentacije. Pritom koristi 8x manje RNK materijala od Moderne, odnosno 2,5x manje od Bionteka, što bi trebalo da znači da će obim proizvodnje moći brže da se poveća.znatno 

 

 

 

Quote

The current mRNA vaccine doses range from 30 micrograms (Pfizer/BioNTech) to 100 micrograms (Moderna). In phase 1 clinical trials, lower doses of the Pfizer/BioNTech vaccine were also active.
 
Could we go lower than this? CureVac has developed a COVID-19 mRNA vaccine with a dose of 12 micrograms through a combination of innovations in mRNA sequence and lipid formulations. However, the details of this remain proprietary.

https://www1.racgp.org.au/newsgp/clinical/four-things-about-mrna-covid-vaccines-researchers

 

Sve to dosta ozbiljno deluje:

 

 

 

 

 

 

https://www.curevac.com/wp-content/uploads/2021/04/20210415_Q4-FY-Earnings-Call_FINAL.pdf

Edited May 7, 20213 yr by vememah